Market by Product (Consumables, Instruments, Imagers) Application (Biomedical & Biochemical Research, Disease Diagnostics, Agriculture, Other Applications) End-user (Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Centers, Other End-users) and Country Outlook | Forecast 2024-2032
Triton’s research analysis states that the western blotting market in North America is estimated to gain revenue at a CAGR of 3.74% over the forecast years 2024-2032.
Several key factors drive the western blotting market in North America. Many pharmaceutical and biotechnology R&D centers are located in the region, benefiting from advanced technology and skilled personnel who are actively working on HIV/AIDS vaccine development. Additionally, extensive scientific and medical research efforts are underway, supported by significant funding from the National Institutes of Health (NIH), particularly in areas like biotechnology and human health. This funding, combined with research advancements in sectors like agriculture and biotechnology, further boosts the demand for western blotting products across the Americas during the forecast period.
The countries researched in this region include:
The United States holds the largest market share, achieving around $268.52 million in 2023.
As per HIV.gov, approximately 1.2 million people are living with HIV in the US and around 13% are unaware of their status. Thus, the demand for accurate diagnostic tools like western blotting remains high to identify and confirm infections.
In 2022, an estimated 31,800 new HIV cases were reported in America, increasing the need for western blotting in confirming diagnoses and supporting early treatment efforts.
Individuals diagnosed with HIV require regular testing and monitoring, driving continued demand for western blotting products in clinical and diagnostic settings.
HIV awareness programs and testing initiatives, particularly in low- and middle-income regions, create further demand for western blotting products, contributing to the market growth of western blotting.
Western Blotting Market Forecast for Canada
According to the Cancer Canadian Statistics 2023 report, an estimated 2 in 5 Canadians will develop cancer in their lifetime. The report also predicted 239,100 new cancer diagnoses and 86,700 cancer mortalities in 2023 alone. These alarming figures drive the demand for advanced diagnostic tools like western blotting techniques, which play a crucial role in cancer research and diagnostics by detecting specific proteins linked to the disease. As cancer incidence rises, the need for accurate testing and ongoing research grows, leading to increased demand for western blotting products and contributing to the market’s expansion in this country.
The studied market is categorized into application, product, and end-user. The end-user segment comprises pharmaceutical & biotechnology companies, research institutes, diagnostic centers, and other end-users. Pharmaceutical and biotechnology companies utilize western blotting techniques in the development of new drugs. The growing applications of western blotting in sectors like food, beverage, and agriculture have also encouraged these companies to invest in research and development to tackle key issues within these fields. As new diseases continue to emerge, pharmaceutical companies will increasingly rely on western blotting for accurate diagnosis and to gain insights necessary for developing innovative treatments.
Contender Analysis in the Western Blotting Market:
LI-COR Inc (doing business as LI-COR Biosciences) is a medical device company specializing in research services. It provides scientific instruments for plant science research and designs, manufactures, and markets instruments, software, reagents, and integrated systems for various fields, including plant biology, biotechnology, drug discovery, and environmental research. LI-COR’s product range includes genomics reagents, western blot reagents, protease assay reagents, Pearl Cam software, optical imaging reagents, and protein gel combs. These products are used in applications such as soil gas flux, eddy covariance, gas analysis, photosynthesis, and light measurement. The company distributes its products across Africa, Asia, Europe, and America, with its headquarters in Lincoln, Nebraska, USA.
The other important contenders in the western blotting market are Thermo Fisher Scientific, Bio-Rad Technologies, Cell Signaling Technology Inc, Bio-Techne Corporation, and Li-Cor Inc.
KEY DELIVERABLES OF THE REPORT:
Market CAGR during the forecasting years 2024-2032
Detailed data highlighting key insights, industry components, and market strategies
Comprehensive information and estimation of the western blotting market revenue growth in North America and its influence on the parent market
In-depth study of forthcoming trends in consumer behavioral patterns
A meticulous analysis of the competitive landscape and Porter’s Five Forces
A wide-ranging study of factors that will challenge the North America western blotting market’s growth during the upcoming years
Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA WESTERN BLOTTING MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE WESTERN BLOTTING MARKET
2.1.1. COVID-19
IMPACT ON THE WESTERN BLOTTING MARKET
2.2. PORTERS
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. KEY
MARKET STRATEGIES
2.3.1. PRODUCT
LAUNCHES
2.3.2. ACQUISITIONS
2.3.3. BUSINESS
EXPANSIONS
2.4. MARKET
DRIVERS
2.4.1. HIGH
DEMAND FOR PROTEOMICS
2.4.2. RISE
IN APPLICATIONS FOR WESTERN BLOTTING
2.4.3. GROWING
OCCURRENCE OF HIV AND LYME DISEASE
2.5. MARKET
CHALLENGES
2.5.1. ADVANCEMENTS
IN SUBSTITUTE TECHNOLOGIES
2.5.2. ELEVATED
ANTIBODY COSTS
2.5.3. REQUIREMENT
FOR IMPROVED PROCEDURAL EFFICIENCY TO ACHIEVE PRECISION
2.6. MARKET
OPPORTUNITIES
2.6.1. RISING
INTEREST IN TAILORED MEDICINE
2.6.2. WESTERN
BLOT INSTRUMENT AUTOMATION
2.6.3. PROGRESS
IN TECHNOLOGICAL ADVANCEMENTS
2.7. ANALYST
PERSPECTIVE
3. NORTH
AMERICA WESTERN BLOTTING MARKET – BY PRODUCT
3.1. CONSUMABLES
3.1.1. REAGENTS
AND BUFFERS
3.1.2. KITS
3.1.3. OTHER
CONSUMABLES
3.2. INSTRUMENTS
3.2.1. GEL
ELECTROPHORESIS INSTRUMENTS
3.2.2. BLOTTING
SYSTEMS
3.2.2.1. DRY
BLOTTING SYSTEMS
3.2.2.2. SEMI-DRY
BLOTTING SYSTEMS
3.2.2.3. WET
BLOTTING SYSTEMS
3.2.3. IMAGERS
3.2.3.1. CHEMILUMINESCENT
IMAGERS
3.2.3.2. FLUORESCENT
IMAGERS
3.2.3.3. OTHER
IMAGERS
4. NORTH
AMERICA WESTERN BLOTTING MARKET – BY APPLICATION
4.1. BIOMEDICAL
& BIOCHEMICAL RESEARCH
4.2. DISEASE
DIAGNOSTICS
4.3. AGRICULTURE
4.4. OTHER
APPLICATIONS
5. NORTH AMERICA
WESTERN BLOTTING MARKET – BY END-USER
5.1. RESEARCH
INSTITUTES
5.2. PHARMACEUTICAL
& BIOTECHNOLOGY COMPANIES
5.3. DIAGNOSTIC
CENTERS
5.4. OTHER
END-USERS
6. NORTH
AMERICA WESTERN BLOTTING MARKET – BY COUNTRY OUTLOOK
6.1. NORTH
AMERICA
6.1.1. COUNTRY
ANALYSIS
6.1.1.1. UNITED
STATES
6.1.1.1.1. UNITED
STATES WESTERN BLOTTING MARKET FORECAST & PROSPECTS
6.1.1.2. CANADA
6.1.1.2.1. CANADA
WESTERN BLOTTING MARKET FORECAST & PROSPECTS
7. COMPETITIVE
LANDSCAPE
7.1. MERCK
KGAA
7.1.1. OVERVIEW
7.1.2. PORTFOLIO
7.1.3. KEY
STRENGTHS
7.1.4. KEY
CHALLENGES
7.2. THERMO
FISHER SCIENTIFIC
7.2.1. OVERVIEW
7.2.2. PORTFOLIO
7.2.3. KEY
STRENGTHS
7.2.4. KEY
CHALLENGES
7.3. BIO-RAD
TECHNOLOGIES
7.3.1. OVERVIEW
7.3.2. PORTFOLIO
7.3.3. KEY
STRENGTHS
7.3.4. KEY
CHALLENGES
7.4. BIO-TECHNE
CORPORATION
7.4.1. OVERVIEW
7.4.2. PORTFOLIO
7.4.3. KEY
STRENGTHS
7.4.4. KEY
CHALLENGES
7.5. CELL
SIGNALING TECHNOLOGY INC
7.5.1. OVERVIEW
7.5.2. PORTFOLIO
7.5.3. KEY
STRENGTHS
7.5.4. KEY
CHALLENGES
7.6. LI-COR
INC
7.6.1. OVERVIEW
7.6.2. PORTFOLIO
7.6.3. KEY
STRENGTHS
7.6.4. KEY
CHALLENGES
7.7. ADVANSTA
INC
7.7.1. OVERVIEW
7.7.2. PORTFOLIO
7.7.3. KEY
STRENGTHS
7.7.4. KEY
CHALLENGES
7.8. AZURE
BIOSYSTEMS INC
7.8.1. OVERVIEW
7.8.2. PORTFOLIO
7.8.3. KEY
STRENGTHS
7.8.4. KEY
CHALLENGES
7.9. PERKINELEMER
INC
7.9.1. OVERVIEW
7.9.2. PORTFOLIO
7.9.3. KEY
STRENGTHS
7.9.4. KEY
CHALLENGES
7.10. LUMIGEN
INC
7.10.1. OVERVIEW
7.10.2. PORTFOLIO
7.10.3. KEY
STRENGTHS
7.10.4. KEY
CHALLENGES
7.11. ROCKLAND
IMMUNOCHEMICALS INC
7.11.1. OVERVIEW
7.11.2. PORTFOLIO
7.11.3. KEY
STRENGTHS
7.11.4. KEY
CHALLENGES
7.12. ENZO
BIOCHEM INC
7.12.1. COMPANY
OVERVIEW
7.12.2. PORTFOLIO
7.12.3. KEY
STRENGTHS
7.12.4. KEY
CHALLENGES
7.13. GENO
TECHNOLOGY INC
7.13.1. COMPANY
OVERVIEW
7.13.2. PORTFOLIO
7.13.3. KEY
STRENGTHS
7.13.4. KEY
CHALLENGES
7.14. STRESSMARQ
BIOSCIENCES INC
7.14.1. COMPANY
OVERVIEW
7.14.2. PORTFOLIO
7.14.3. KEY
STRENGTHS
7.14.4. KEY
CHALLENGES
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA WESTERN
BLOTTING MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 2: LIST OF PRODUCT
LAUNCHES
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF BUSINESS
EXPANSIONS
TABLE 5: NORTH AMERICA WESTERN
BLOTTING MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 6: NORTH AMERICA WESTERN
BLOTTING MARKET, BY CONSUMABLES, 2024-2032 (IN $ MILLION)
TABLE 7: NORTH AMERICA WESTERN
BLOTTING MARKET, BY INSTRUMENTS, 2024-2032 (IN $ MILLION)
TABLE 8: NORTH AMERICA WESTERN
BLOTTING MARKET, BY BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
TABLE 9: NORTH AMERICA WESTERN
BLOTTING MARKET, BY IMAGERS, 2024-2032 (IN $ MILLION)
TABLE 10: NORTH AMERICA
WESTERN BLOTTING MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)
TABLE 11: NORTH AMERICA
WESTERN BLOTTING MARKET, BY END-USER, 2024-2032 (IN $ MILLION)
TABLE 12: NORTH AMERICA
WESTERN BLOTTING MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: NORTH AMERICA
WESTERN BLOTTING MARKET, BY PRODUCT, 2023 & 2032 (IN %)
FIGURE 3: NORTH AMERICA
WESTERN BLOTTING MARKET, BY CONSUMABLES, 2024-2032 (IN $ MILLION)
FIGURE 4: NORTH AMERICA
WESTERN BLOTTING MARKET, BY CONSUMABLES, 2023 & 2032 (IN %)
FIGURE 5: NORTH AMERICA
WESTERN BLOTTING MARKET, BY REAGENTS AND BUFFERS, 2024-2032 (IN $ MILLION)
FIGURE 6: NORTH AMERICA
WESTERN BLOTTING MARKET, BY KITS, 2023 & 2032 (IN %)
FIGURE 7: NORTH AMERICA
WESTERN BLOTTING MARKET, BY OTHER CONSUMABLES, 2024-2032 (IN $ MILLION)
FIGURE 8: NORTH AMERICA
WESTERN BLOTTING MARKET, BY INSTRUMENTS, 2023 & 2032 (IN %)
FIGURE 9: NORTH AMERICA
WESTERN BLOTTING MARKET, BY GEL ELECTROPHORESIS INSTRUMENTS, 2024-2032 (IN $
MILLION)
FIGURE 10: NORTH AMERICA
WESTERN BLOTTING MARKET, BY BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 11: NORTH AMERICA
WESTERN BLOTTING MARKET, BY BLOTTING SYSTEMS, 2023 & 2032 (IN %)
FIGURE 12: NORTH AMERICA
WESTERN BLOTTING MARKET, BY DRY BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 13: NORTH AMERICA
WESTERN BLOTTING MARKET, BY SEMI-DRY BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 14: NORTH AMERICA
WESTERN BLOTTING MARKET, BY WET BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 15: NORTH AMERICA
WESTERN BLOTTING MARKET, BY IMAGERS, 2023 & 2032 (IN %)
FIGURE 16: NORTH AMERICA
WESTERN BLOTTING MARKET, BY CHEMILUMINESCENT IMAGERS, 2024-2032 (IN $ MILLION)
FIGURE 17: NORTH AMERICA
WESTERN BLOTTING MARKET, BY FLUORESCENT IMAGERS, 2024-2032 (IN $ MILLION)
FIGURE 18: NORTH AMERICA
WESTERN BLOTTING MARKET, BY OTHER IMAGERS, 2024-2032 (IN $ MILLION)
FIGURE 19: NORTH AMERICA
WESTERN BLOTTING MARKET, BY APPLICATION, 2023 & 2032 (IN %)
FIGURE 20: NORTH AMERICA
WESTERN BLOTTING MARKET, BY BIOMEDICAL & BIOCHEMICAL RESEARCH, 2024-2032
(IN $ MILLION)
FIGURE 21: NORTH AMERICA
WESTERN BLOTTING MARKET, BY DISEASE DIAGNOSTICS, 2024-2032 (IN $ MILLION)
FIGURE 22: NORTH AMERICA
WESTERN BLOTTING MARKET, BY AGRICULTURE, 2024-2032 (IN $ MILLION)
FIGURE 23: NORTH AMERICA
WESTERN BLOTTING MARKET, BY OTHER APPLICATIONS, 2024-2032 (IN $ MILLION)
FIGURE 24: NORTH AMERICA
WESTERN BLOTTING MARKET, BY END-USER, 2023 & 2032 (IN %)
FIGURE 25: NORTH AMERICA
WESTERN BLOTTING MARKET, BY RESEARCH INSTITUTES, 2024-2032 (IN $ MILLION)
FIGURE 26: NORTH AMERICA
WESTERN BLOTTING MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,
2024-2032 (IN $ MILLION)
FIGURE 27: NORTH AMERICA
WESTERN BLOTTING MARKET, BY DIAGNOSTIC CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 28: NORTH AMERICA
WESTERN BLOTTING MARKET, BY OTHER END-USERS, 2024-2032 (IN $ MILLION)
FIGURE 29: NORTH AMERICA
WESTERN BLOTTING MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 30: UNITED STATES
WESTERN BLOTTING MARKET 2024-2032 (IN $ MILLION)
FIGURE 31: CANADA WESTERN
BLOTTING MARKET 2024-2032 (IN $ MILLION)